While we found a positive correlation of sGFAP with axial RSSI diameter, suggesting that sGFAP levels increase with the size of ischemic infarction, neither baseline nor follow-up GFAP levels were related to clinical stroke severity (according to the NIHSS) or functional neurological outcome (rated by the mRS). This evidence concerns the gene GFAP and stroke disorder.